BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19082784)

  • 1. Role of advanced MR imaging modalities in diagnosing cerebral gliomas.
    Scarabino T; Popolizio T; Trojsi F; Giannatempo G; Pollice S; Maggialetti N; Carriero A; Di Costanzo A; Tedeschi G; Salvolini U
    Radiol Med; 2009 Apr; 114(3):448-60. PubMed ID: 19082784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
    Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings.
    Chiang IC; Kuo YT; Lu CY; Yeung KW; Lin WC; Sheu FO; Liu GC
    Neuroradiology; 2004 Aug; 46(8):619-27. PubMed ID: 15243726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
    Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy.
    Di Costanzo A; Scarabino T; Trojsi F; Giannatempo GM; Popolizio T; Catapano D; Bonavita S; Maggialetti N; Tosetti M; Salvolini U; d'Angelo VA; Tedeschi G
    Neuroradiology; 2006 Sep; 48(9):622-31. PubMed ID: 16752135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of advanced MRI in differentiating high-grade from low-grade gliomas in a setting of routine service.
    Chawalparit O; Sangruchi T; Witthiwej T; Sathornsumetee S; Tritrakarn S; Piyapittayanan S; Chaicharoen P; Direksunthorn T; Charnchaowanish P
    J Med Assoc Thai; 2013 Oct; 96(10):1365-73. PubMed ID: 24350420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric evaluation of low grade gliomas at follow-up: comparison between diffusion and perfusion MR with (18)F-FDOPA PET.
    Rossi Espagnet MC; Romano A; Mancuso V; Cicone F; Napolitano A; Scaringi C; Minniti G; Bozzao A
    Br J Radiol; 2016 Oct; 89(1066):20160476. PubMed ID: 27505026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
    Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T
    Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.
    Floeth FW; Pauleit D; Wittsack HJ; Langen KJ; Reifenberger G; Hamacher K; Messing-Jünger M; Zilles K; Weber F; Stummer W; Steiger HJ; Woebker G; Müller HW; Coenen H; Sabel M
    J Neurosurg; 2005 Feb; 102(2):318-27. PubMed ID: 15739561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects.
    Fink JR; Carr RB; Matsusue E; Iyer RS; Rockhill JK; Haynor DR; Maravilla KR
    J Magn Reson Imaging; 2012 Jan; 35(1):56-63. PubMed ID: 22002882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent cerebral gliomas in MRI and Iodine-123[corrected]-alpha-methyl-tyrosine SPECT: the use of digitally fused images.
    Grzelak P; Górska-Chrzastek M; Gajewicz W; Kuśmierek J; Tybor K; Stefańczyk L
    Nucl Med Rev Cent East Eur; 2005; 8(2):94-9. PubMed ID: 16437393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [(18)F]-fluoro-L-thymidine PET and advanced MRI for preoperative grading of gliomas.
    Collet S; Valable S; Constans JM; Lechapt-Zalcman E; Roussel S; Delcroix N; Abbas A; Ibazizene M; Bernaudin M; Barré L; Derlon JM; Guillamo JS
    Neuroimage Clin; 2015; 8():448-54. PubMed ID: 26106569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfusion and permeability MR imaging of gliomas.
    Shiroishi MS; Habibi M; Rajderkar D; Yurko C; Go JL; Lerner A; Mogensen MA; Kim PE; Boyko OB; Zee CS; Law M
    Technol Cancer Res Treat; 2011 Feb; 10(1):59-71. PubMed ID: 21214289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced MR imaging in hemispheric low-grade gliomas before surgery; the indications and limits in the pediatric age.
    Gaudino S; Russo R; Verdolotti T; Caulo M; Colosimo C
    Childs Nerv Syst; 2016 Oct; 32(10):1813-22. PubMed ID: 27659824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroradiological viewpoint on the diagnostics of space-occupying brain lesions.
    Faehndrich J; Weidauer S; Pilatus U; Oszvald A; Zanella FE; Hattingen E
    Clin Neuroradiol; 2011 Sep; 21(3):123-39. PubMed ID: 21538040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of perfusion MRI in differentiating low-grade and high-grade gliomas: advanced MRI in glioma, A Siriraj project.
    Direksunthorn T; Chawalparit O; Sangruchi T; Witthiwej T; Tritrakarn SO; Piyapittayanan S; Charnchaowanish P; Pornpunyawut P; Sathornsumetee S
    J Med Assoc Thai; 2013 Sep; 96(9):1183-90. PubMed ID: 24163995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas.
    Catalaa I; Henry R; Dillon WP; Graves EE; McKnight TR; Lu Y; Vigneron DB; Nelson SJ
    NMR Biomed; 2006 Jun; 19(4):463-75. PubMed ID: 16763973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
    Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
    Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of perfusion-weighted imaging in brain glioma: a prospective study.
    Chaskis C; Stadnik T; Michotte A; Van Rompaey K; D'Haens J
    Acta Neurochir (Wien); 2006 Mar; 148(3):277-85; discussion 285. PubMed ID: 16421765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.